D. Esser

发表

Biological activity, membrane‐targeting modification, and crystallization of soluble human decay accelerating factor expressed in E. coli

G. Smith, R. Smith, S. Lea, 2004, Protein science : a publication of the Protein Society.

APT070 (Mirococept), a membrane‐localised complement inhibitor, inhibits inflammatory responses that follow intestinal ischaemia and reperfusion injury

M. Teixeira, D. Esser, D. G. Souza, 2005, British journal of pharmacology.

Structure determination of the Ras-binding domain of the Ral-specific guanine nucleotide exchange factor Rlf.

R. Wolthuis, A. Wittinghofer, D. Esser, 1998, Biochemistry.

NiH3IO6×6 H2O ‐ Crystal Structures and Vibrational Spectra.

D. Esser, H. Lutz, Z. Zhang, 1996 .

A hyperthermostable bacterial histone-like protein as an efficient mediator for transfection of eukaryotic cells

G. Böhm, A. Yoshiki, M. Kusakabe, 2000, Nature Biotechnology.

Complement regulation at the molecular level: the structure of decay-accelerating factor.

P Lukacik, R. Dwek, M. Wormald, 2004, Proceedings of the National Academy of Sciences of the United States of America.

Protection of erythrocytes from human complement-mediated lysis by membrane-targeted recombinant soluble CD59: a new approach to PNH therapy.

G. Smith, R. Smith, D. Esser, 2006, Blood.

Engineering Control of Complement Inhibition at the Cell Surface

R. Smith, D. Esser, S. Ridley, 2004 .

The HU protein from Thermotoga maritima: recombinant expression, purification and physicochemical characterization of an extremely hyperthermophilic DNA-binding protein.

G. Böhm, R. Jaenicke, R. Rudolph, 1999, Journal of molecular biology.

Complement Inhibitor APT070 Dramatically Reduces the Need for Resuscitation and Improves Survival in Controlled Isobaric Rat Hemorrhage Model

D. Purger, R. Smith, C. Alving, 2004 .

Synthesis and use of a pseudo‐cysteine for native chemical ligation

D. Esser, R. Broadbridge, Andrew P. G. Beevers, 2003, Journal of Peptide Science.